| RS2122436225 |
FTL
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuroferritinopathy, Neuroferritinopathy |
| RS2122437453 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS2122440638 |
OPA3
|
Health Risk |
Likely pathogenic |
3-Methylglutaconic aciduria type 3, 3-Methylglutaconic aciduria type 3 |
| RS2122461010 |
GYS1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS2122474072 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122477513 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122495575 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2122503565 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122503902 |
SLC4A11
|
Health Risk |
Pathogenic/Likely pathogenic |
Corneal dystrophy-perceptive deafness syndrome, Congenital hereditary endothelial dystrophy of cornea |
| RS2122506319 |
CSNK2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2122507340 |
POLD1
|
Health Risk |
Pathogenic |
Carcinoma of pancreas, Carcinoma of pancreas |
| RS2122509398 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mandibular hypoplasia-deafness-progeroid syndrome, Hereditary cancer-predisposing syndrome |
| RS2122509664 |
GYS1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS2122509752 |
GYS1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS2122516373 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122520177 |
GYS1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS2122520738 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122521078 |
POLD1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2122521678 |
CSNK2A1
|
Health Risk |
Likely pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS2122521881 |
CSNK2A1
|
Health Risk |
Likely pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS2122523501 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122525139 |
GYS1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS2122525167 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122525708 |
GYS1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS2122527578 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122531973 |
CSNK2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS2122537652 |
CSNK2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Okur-Chung neurodevelopmental syndrome, CSNK2A1-related disorder |
| RS2122541178 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122542952 |
SLC4A11
|
Health Risk |
Likely pathogenic |
— |
| RS2122548698 |
SLC4A11
|
Health Risk |
Likely pathogenic |
— |
| RS2122554800 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122554995 |
SLC4A11
|
Health Risk |
Likely pathogenic |
— |
| RS2122557589 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122559586 |
CSNK2A1
|
Health Risk |
Pathogenic |
— |
| RS2122559628 |
CSNK2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Okur-Chung neurodevelopmental syndrome, CSNK2A1-related disorder |
| RS2122587910 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122588719 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122593684 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122595010 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122595154 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122595262 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122595645 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122595693 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122595849 |
JAG1
|
Health Risk |
Likely pathogenic |
Hepatic Ductular Hypoplasia, Hepatic Ductular Hypoplasia |
| RS2122595901 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122595945 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122596452 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122596864 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Tetralogy of Fallot |
| RS2122597170 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122597239 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122597276 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122597289 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122597347 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122598522 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS2122598564 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122600427 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122600431 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122600550 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122601454 |
POFUT1
|
Health Risk |
Pathogenic |
Dowling-Degos disease 2, Dowling-Degos disease 2 |
| RS2122602312 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122602509 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122602893 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122603085 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122603096 |
JAG1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2122604461 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS2122604480 |
JAG1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, axonal |
| RS2122606113 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122606128 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122606192 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122606213 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122606277 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122606362 |
JAG1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, axonal |
| RS2122607604 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122607689 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122607723 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Charcot-Marie-Tooth disease |
| RS2122607772 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122608790 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122608799 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122608890 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122609680 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122609879 |
FKRP
|
Health Risk |
Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2122609947 |
FKRP
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 |
| RS2122610459 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122611488 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS2122611660 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122612115 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Inborn genetic diseases |
| RS2122612431 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS2122613554 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122613705 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122614368 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122614453 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122614562 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122615095 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Arteriohepatic dysplasia |
| RS2122615158 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122616718 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy type B5 |
| RS2122617005 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2122620277 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2122620454 |
FKRP
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2122620867 |
FKRP
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2122621481 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |